期刊文献+

抑郁症与强迫症患者治疗前后血清脑源性神经营养因子、白介素-2及白介素-6水平变化及其临床意义 被引量:13

The level changes of brain-derived neurotrophic factors,interleukin-2 and interleukin-6 in serum of patients with depression and obsessive-compulsive disorder before and after treatment and their clinical significance
暂未订购
导出
摘要 目的探讨抑郁症与强迫症患者治疗前后血清脑源性神经营养因子(BDNF)、白介素-2(IL-2)、白介素-6(IL-6)水平变化及影响因素。方法患者按症状分为抑郁症组、强迫症组、对照组,每组30例。抑郁症组和强迫症组在帕罗西汀治疗基础上,配合心理治疗。酶联免疫吸附法(ELISA)检测3组血清BDNF、IL-2、IL-6水平。治疗前后进行量表评定,抑郁症状评定采用汉密尔顿抑郁量表(HAMD),强迫症状评定采用耶鲁-布朗强迫量表(Y-BOCS)。对抑郁症、强迫症患者血清BDNF、IL-2、IL-6水平与HAMD总分值、Y-BOCS总分值、病程、年龄、性别之间进行相关分析。结果治疗后抑郁症组血清BDNF水平较治疗前明显升高,IL-2、IL-6水平较治疗前明显降低,但BDNF水平仍明显低于对照组。治疗后强迫症组血清BDNF水平较治疗前明显升高,IL-2水平较治疗前明显降低,但BDNF水平仍明显低于对照组。抑郁症组血清BDNF水平与HAMD评分呈负相关(P<0.05),血清IL-2、IL-6水平与HAMD评分呈正相关。强迫症组血清BDNF水平与Y-BOCS评分呈负相关,血清IL-6与Y-BOCS评分呈正相关。结论 BDNF、IL-2、IL-6为抑郁症、强迫症的鉴别及诊疗提供可能依据。 Objective To explore the level changes of brain-derived neurotrophic factors (BDNF), interleukin-2 (IL-2) and interleukin-6 (IL-6) in serum of patients with depression and ob- sessive-compulsive disorder before and after treatment and the influential factors. Methods There were 30 cases in depression group (depression patients), 30 cases in obsessive-compulsive disorder group (patients with obsessive-compulsive disorder) and 30 cases in control group. On the basis of paroxetine therapy, the psychological therapy was administered in the depression group and the ob- sessive-compulsive disorder group. The levels of BDNF, IL-2 and IL-6 in serum of the three groups were detected by enzyme-linked immunosorbent assay (ELISA). Before and after treatment, the scale assessment was conducted. Hamilton depression rating scale (HAMD) was applied to assess the symptoms of depression while yale-brown obsessive compulsive scale (Y-BOCS) to evaluate ob- sessive compulsive symptoms. The relative analysis was conducted between the levels of BDNF, IL-2 and IL6 in serum of patients with depression and obsessive - compulsive disorder and HAMD total score, Y-BOC~ total score, disease duration, age and gender. Results After treatment, serum BDNF level in the depression group significantly increased, while the levels of IL-2 and IL-6 obvi- ously decreased, but BDNF level was still lower than that in the control group. Serum BDNF lev- el in obsessive-compulsive disorder group conspicuously elevated, whereas IL-2 level markedly re- duced, but BDNF level was still lower than that in the control group. In the depression group, serum BDNF level was associated with HAMD score negatively, while the levels of IL-2 and IL-6 in serum were related to HAMD score positively. In the obsessive-compulsive disorder group, serum BDNF level is associated with Y-BOCS score negatively, while serum IL6 was related to Y -BOCS score positively. Conclusion BDNI~, lg_2 and IL-6 can provide possible evidences for the i- dentification and diagnosis of depression and obsessive-compulsive disorder.
出处 《实用临床医药杂志》 CAS 2013年第1期37-40,共4页 Journal of Clinical Medicine in Practice
基金 中国高校医学期刊临床专项资金(11220224)
关键词 抑郁症 强迫症 脑源性神经营养因子 白介素-2 白介素-6 depression obsessive-compulsive disorder brain-derived neurotrophic factor interleukin-2 interleukin-6
  • 相关文献

参考文献17

  • 1Shimizu E,Hashimoto K,Okamura' N. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants[J].Biological Psychiatry,2003,(01):70.
  • 2Gervasoni N,Aubry J M,Bondolfi G. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode[J].Neuropsychobiology,2005,(04):234.
  • 3Karege F,Pefet G,Bondolfi G. Decreased serum brain-derived neurotrophlc factor levels in major depressed patients[J].Psychiatry Research,2002,(02):143.
  • 4李晓照,陈泽奇,胡随瑜,张宏耕.抑郁症患者血清BDNF水平与相关因素分析[J].中国临床心理学杂志,2005,13(3):312-313. 被引量:40
  • 5Piccinni A,Marazziti D,catena M. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during l year of antidepressant treatments[J].Journal of Affective Disorders,2008,(1-3):279.
  • 6Paats M S,Bergen I M,Hanselaar W E. Local and systemic cytokine profiles in non-severe and severe community-acquired pneumonia[J].European Respiratory Journal,2012.
  • 7Jang M J,Kim H S,Lee H G. Placenta-Derived Mesenchymal Stem Cells Have an Immunomodulatory Effect That Can Control Acute Graft-Versus-Host Disease in Mice[J].Acta Haematologica,2012,(04):197.
  • 8Kagaya A,Takebagashi M. Plasma concentrations of interleukin-lbeta,interleukin-6,soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan[J].Neuropsychobiology,2001,(01):59.
  • 9Black J L,Larnke G T,Walikonis J E. Serologic survey of patients with obsessive compulsive disorder for neurou specific and other autoantibodies[J].Psychiatry Research,1998,(03):371.
  • 10Murphy T K,Goodman W K,Fudge M W. B lymphocyte antigen D8/17:a peripheral marker for childhoodonset obsessive compulsive disorder and ToureRe's syndrome[J].American Journal of Psychiatry,1997,(03):402.

二级参考文献68

  • 1贾福军,侯彩兰.抑郁障碍性别差异因素的研究[J].中国行为医学科学,2007,16(5):476-478. 被引量:11
  • 2Zheng Z, Yenari MA. Post-ischemic inflammation: molecular mechanisms and therapeutic implications [J]. Neurol Res, 2004, 26 (8): 884-92.
  • 3Kwak HB, Sun HM, Ha H, et al. Tanshinone IIA suppresses inflammatory bone loss by inhibiting the synthesis of prostaglandin E2 in osteoblasts[J]. Eur J Pharmacol, 2008, 601(1-3): 30-7.
  • 4Fu J, Huang H, Liu J, et al. Tanshinone HA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis [J]. Eur J Pharmacol, 2007, 568(1-3): 213-21.
  • 5Han JY, Fan JY, Horie Y, et al. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion [J]. Pharmacol Ther, 2008, 117(2): 280-95.
  • 6Pahl HL. Activators and target genes of Rel/NF-kappaB transcription factors [J]. Oncogene, 1999, 18(49): 6853-66.
  • 7Schwaninger M, Inta I,Herrmann O. NF-kappaB signalling in cerebral ischaemia[J]. Biochem Soc Trans, 2006, 34(Pt 6): 1291-4.
  • 8Valen G. Signal transduction through nuclear factor kappa B in ischemia-reperfusion and heart failure [J ]. Basic Res Cardiol, 2004, 99(1): 1-7.
  • 9Auron PE. The interleuldn 1 receptor: ligand interactions and signal transduction [J]. Cytokine Growth Factor Rev, 1998, 9 (3-4): 221-37.
  • 10Li X, Wang X. Application of real-time polymerase chain reaction for the quantitation of interleukin-1beta mRNA upregulation in brain ischemic tolerance [Jl. Brain Res Brain Res Protoc, 2000, 5 (2): 211-7.

共引文献89

同被引文献118

  • 1李丽萍,华金双,兰敬昀,孙忠人.针刺百会和太冲穴对慢性应激抑郁模型大鼠细胞因子的影响[J].针灸临床杂志,2006,22(9):49-50. 被引量:12
  • 2徐晔,王喜今,关晓峰.单、双相抑郁症患者血清白介素-6水平的比较[J].医学临床研究,2007,24(9):1541-1543. 被引量:1
  • 3黄晓舞,谢婷婷,王东晓,王虹,刘屏.远志醇提物的抗抑郁作用[J].中国药物应用与监测,2007,4(4):22-25. 被引量:29
  • 4张明园.精神病科量表评定手册[M].长沙:湖南科学技术出版社,1993.34-38.
  • 5Monje FJ,Cabatic M,Divisch I,et al.Constant darkness induces IL-6-dependent depression-like behavior through the NF-κB signaling pathway[J].J Neurosci,2011,31(25):9075-9083.
  • 6李一兰,邓河晃,张璐璐.重性抑郁障碍治疗前后血清脑源性神经营养因子水平的研究//中华医学会第十次全国精神医学学术会议论文汇编,2012:15.
  • 7Simpson H B,Foa E B,Liebowitz M R,et al.Cognitivebehavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder:a randomized clinical trial[J].JAMA Psychiatry,2013,70(11):1190-1199.
  • 8Dold M,Aigner M,Lanzenberger R,et al.Antipsychotic augmentation of serotonin reuptake inhibitors in treatmentresistant obsessive-compulsive disorder:a meta-analysis of double-blind,randomized,placebo-controlled trials[J].International Journal of Neuropsychopharmacology,2013,16(3):557-574.
  • 9Tsaltas Eleftheria,Kontis Dimitris,Chrysikakou Sofia,etal,Reinforced spatial alternation as an animal model of obsessivecompulsive disorder(OCD):investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology[J].Biological Psychiatry,2005,57(10):1176-1185.
  • 10Catapano Francesco,Perris Francesco,Masella Mariangela,et al.Obsessive-compulsive disorder:a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study[J].Journal of Psychiatric Research,2006,40(6):502-510.

引证文献13

二级引证文献108

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部